2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia
59
Precursor Cell Lymphoblastic Leukemia-Lymphoma
54
Lymphoma
49
Burkitt Lymphoma
39
Lymphoma, Large B-Cell, Diffuse
37
Lymphoma, Follicular
37
Myelodysplastic Syndromes
34
Lymphoma, Non-Hodgkin
34
Multiple Myeloma
32
Leukemia, Myeloid, Acute
31
Leukemia, Myeloid, Chronic-Phase
30
Leukemia, Myeloid, Accelerated Phase
28
Lymphoma, Large-Cell, Immunoblastic
27
Leukemia, Lymphocytic, Chronic, B-Cell
27
Hodgkin Disease
22
Blast Crisis
22
Lymphoma, Mantle-Cell
21
Lymphoma, B-Cell, Marginal Zone
21
Graft vs Host Disease
21
Neoplasms, Plasma Cell
20
Myeloproliferative Disorders
20
Dendritic Cell Sarcoma, Interdigitating
20
Recurrence
19
Leukemia, Myelomonocytic, Chronic
17
Leukemia, Biphenotypic, Acute
17
Congenital Abnormalities
17
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
15
Anemia, Refractory, with Excess of Blasts
15
Primary Myelofibrosis
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Interventions
Cyclophosphamide
32
Etoposide
18
romidepsin
17
fludarabine
17
Vincristine
17
Doxorubicin
16
Rituximab
14
Prednisone
14
Melphalan
14
Gemcitabine
13
Brentuximab Vedotin
13
Lenalidomide
12
Peripheral Blood Stem Cell Transplantation
11
Cytarabine
11
Whole-Body Irradiation
10
Biopsy
10
10-propargyl-10-deazaaminopterin
10
pembrolizumab
9
fludarabine phosphate
9
Specimen Handling
9
Busulfan
9
Mycophenolic Acid
8
Granulocyte Colony-Stimulating Factor
8
Depsipeptides
8
Carmustine
8
Bortezomib
8
duvelisib
7
Vorinostat
7
Methotrexate
7
Magnetic Resonance Spectroscopy
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
Methylprednisolone
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled